A qualitative investigation of Veterans' perceived barriers to medication treatment for opioid use disorder

Abstract: Aim: Opioid Use Disorder (OUD) is a significant public health concern for ~70,000 United States veterans. While Medication treatment for Opioid Use Disorder (MOUD; e.g., buprenorphine, methadone) is a first-line intervention, dropout is common and associated with dramatic increases in morbidity and mortality. Understanding patient perspectives on MOUD care barriers is vital, but research has primarily examined civilian populations. Guided by a social-ecological framework of the opioid crisis, we qualitatively examined perceived barriers to MOUD among veteran patients. Methods: We conducted individual semi-structured interviews with veterans receiving opioid agonist treatment and utilized rapid qualitative analytic methods. A team-based approach was used to develop a start-list of semi-structured interview questions. Individual semi-structured interviews were subsequently conducted. Interview templates were independently coded by each interviewer, who then convened to discuss and refine code definitions, develop transcript summary templates, organize codes into hierarchical structures, and refine categories into domains through consensus. Results: A total of 15 veterans (M[SD]age = 60.05[10.77], 86.67% White, Non-Hispanic/Latino, 93.33% male sex assigned at birth, 40% prescribed methadone, 60% prescribed buprenorphine) participated. The social-ecological levels with the most prominent identified barriers were Individual (Co-Occurring Symptoms, Daily Stressors, Motivational Impairments, Self-Stigma, and Negative Reactions to MOUD Medications) and Community (Rigid Treatment Structure, Provider Rapport and Communication, Administrative and Logistical Challenges, Holistic Recovery Needs, and Treatment-based Stigma); however, Interpersonal (Risky Socialization, Social Stigma) and Societal barriers (Societal Stigma) were also identified. Conclusions: Veteran emphasis on individual and community-based barriers suggests a need for greater adjunctive support to facilitate improved quality of life, increase treatment plan transparency, and foster patient-provider communication throughout MOUD (induction, maintenance, and, if desired, tapering). Additionally, stigma-related barriers reported across ecological domains indicate the need for continued patient support and multi-faceted interventions.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.

    Mental Health Peer reviewed